Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study.
Rajagopalan H, Cherrington AD, Thompson CC, Kaplan LM, Rubino F, Mingrone G, Becerra P, Rodriguez P, Vignolo P, Caplan J, Rodriguez L, Galvao Neto MP. Rajagopalan H, et al. Among authors: vignolo p. Diabetes Care. 2016 Dec;39(12):2254-2261. doi: 10.2337/dc16-0383. Epub 2016 Aug 12. Diabetes Care. 2016. PMID: 27519448 Clinical Trial.
Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study).
van Baar ACG, Devière J, Hopkins D, Crenier L, Holleman F, Galvão Neto MP, Becerra P, Vignolo P, Rodriguez Grunert L, Mingrone G, Costamagna G, Nieuwdorp M, Guidone C, Haidry RJ, Hayee B, Magee C, Carlos Lopez-Talavera J, White K, Bhambhani V, Cozzi E, Rajagopalan H, J G H M Bergman J. van Baar ACG, et al. Among authors: vignolo p. Diabetes Res Clin Pract. 2022 Feb;184:109194. doi: 10.1016/j.diabres.2022.109194. Epub 2022 Jan 13. Diabetes Res Clin Pract. 2022. PMID: 35032562 Free article. Clinical Trial.
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study.
van Baar ACG, Holleman F, Crenier L, Haidry R, Magee C, Hopkins D, Rodriguez Grunert L, Galvao Neto M, Vignolo P, Hayee B, Mertens A, Bisschops R, Tijssen J, Nieuwdorp M, Guidone C, Costamagna G, Devière J, Bergman JJGHM. van Baar ACG, et al. Among authors: vignolo p. Gut. 2020 Feb;69(2):295-303. doi: 10.1136/gutjnl-2019-318349. Epub 2019 Jul 22. Gut. 2020. PMID: 31331994 Free PMC article. Clinical Trial.
[Non-alcoholic fatty liver disease in type 2 diabetes: a joint statement of the Chilean Hepatology and Diabetology Societies].
Arab JP, Castro L, Gómez PC, Vignolo P, Arrese M, Barrera F, Castro F, Díaz LA, Donoso A, Elgueta K, González K, González MI, Moreno M, Lazarte R, Poniachik J, Salman P, Valderas JP. Arab JP, et al. Among authors: vignolo p. Rev Med Chil. 2021 Sep;149(9):1360-1371. doi: 10.4067/S0034-98872021000901360. Rev Med Chil. 2021. PMID: 35319691 Free article. Spanish. No abstract available.
Benign Neonatal Sleep Myoclonus Evokes Somatosensory Responses.
Losito E, Eisermann M, Vignolo P, Hovhannisyan S, Magny JF, Kaminska A. Losito E, et al. Among authors: vignolo p. J Clin Neurophysiol. 2017 Nov;34(6):484-491. doi: 10.1097/WNP.0000000000000412. J Clin Neurophysiol. 2017. PMID: 28922194
18 results